Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 01,2018
Early Liver Cancer Detection through Glycolytic Genes
The advantages of early detection in cancer screening cannot be overstated. Mountains of evidence exist showing the importance of intervening quickly not only to halt the spread of disease but also that survival rates improve dramatically for nearly all forms of cancer. Yet, identifying early markers of cancer remains a challenge for scientists. Although now,Read more
More
Early Liver Cancer Detection through Glycolytic Genes
Nov 01,2018
Technical Guidelines for Drug Safety Pharmacology Research
The purpose of drug safety pharmacology research is to discover unexpected pharmacodynamic properties of the test substance that may be related to the clinical safety of humans, and to evaluate the adverse reactions and/or pathology of the test substance observed in toxicological tests and/or clinical studies The purpose of the QT interval study is mainlyRead more
More
Technical Guidelines for Drug Safety Pharmacology Research
Oct 31,2018
Softening Up Chemo-Resistant Cancer Cells
DNA-damaging agents (DDAs) make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance – either present in cancer cells from the disease onset or arising during treatment.   Now, scientists at the University of California San Diego (UCSD) have identified a gene that is involvedRead more
More
Oct 31,2018
Growth Factor Significantly Impacts Fat and Carb Metabolism
A protein that has been under study for its role in cancer could represent a surprising new treatment for metabolic syndrome and associated disorders, such as type 2 diabetes and fatty liver disease. Studies in an obese mouse model by scientists at the Georgetown Lombardi Comprehensive Cancer Center showed that forcing expression of the naturalRead more
More
Growth Factor Significantly Impacts Fat and Carb Metabolism
Oct 30,2018
Probiotics Are Not Always Good for You
Through research on gut inflammation, researchers have found that probiotics are not always 'good bacteria', and may not be good for everyone. Studies using a novel human "gut-inflammation-on-a-chip” suggest that probiotic bacteria may not always be a benefit to our health. Woojung Shin, Ph.D. student, and Hyun Jun Kim, Ph.D., assistant professor in the departmentRead more
More
Oct 30,2018
Immunocompromised Patients Could Get Help from New Vaccine Strategy
Bolstering the immune system is not a new strategy when trying to protect against deadly pathogens, yet for those individuals that are immunocompromised, this therapeutic approach presents a particular challenge. For instance, while fungal pathogens rarely sicken healthy individuals, the incidence of fungal infections in people with HIV/AIDS or other immune deficiencies has risen sharplyRead more
More
Immunocompromised Patients Could Get Help from New Vaccine Strategy
Oct 29,2018
Infant Microbiome Develops in Three Stages
By now, we know that the microbiome is important. But, despite all of the attention, exactly what role our commensal bacteria play in human disease remains largely unknown. Two papers were published back-to-back in Nature, the largest clinical microbiome studies done to date, that are trying to answer this question.   In one study, titled "TemporalRead more
More
Oct 29,2018
Ear Infection Susceptibility Gene Identified
Those that have been affected by middle ear infections in their youth can attest to the anguish that this condition can have on daily life. Now, Researchers at the University of Colorado (CU) Anschutz Medical Campus have found multiple genetic variants within the FUT2 gene that makes some people especially susceptible to middle ear infections.Read more
More
Ear Infection Susceptibility Gene Identified
Oct 26,2018
SIDS Link to Serotonin Neurons Strengthened
Sudden infant death syndrome or SIDS (also known as "cot death” or "crib death”) is the leading cause of death of young infants in the western world. Although the link between serotonin-producing neurons and their role in the regulation of breathing has been at the heart of SIDS research for many years, the cause ofRead more
More
SIDS Link to Serotonin Neurons Strengthened
Oct 26,2018
Anti-Obesity "Biochemical Cigarette" Exploits Body's Responses to Cold and Smoking
Researchers in Europe and Australia have developed an anti-obesity "chemical cigarette" that exploits the body's natural responses to both cold exposure and smoking. The new approach uses two chemicals to boost energy expenditure and fat burning, while simultaneously dampening appetite, improving lipid metabolism, and reversing glucose intolerance. Tested in obese mice, the weight-loss approach couples.
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->